Anbio Biotechnology Class A Ordinary Shares (NNNN) — Financial Flexibility Index

Latest as of December 2024: 0.93x

Anbio Biotechnology Class A Ordinary Shares (NNNN) has a Financial Flexibility Index of 0.93x as of December 2024. Free cash flow of $1.60 Million (operating CF $1.60 Million minus capex $1.67) represents 1% of total liabilities ($1.73 Million). Also explore how fast is Anbio Biotechnology Class A Ordinary Sha growing its equity to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

0.93x
Free Cash Flow / Total Liabilities

Free Cash Flow

$1.60 Million
Operating CF − Capex

Total Liabilities

$1.73 Million
USD

Capital Expenditures

$1.67
USD

Anbio Biotechnology Class A Ordinary Shares Financial Flexibility Index (2021–2024)

Historical Financial Flexibility Index trend for Anbio Biotechnology Class A Ordinary Shares across 4 annual periods. Check financial resilience of Anbio Biotechnology Class A Ordinary Sha to evaluate the company's liquid asset resilience ratio.

Annual Financial Flexibility Index for Anbio Biotechnology Class A Ordinary Shares (2021–2024)

Year-by-year free cash flow to debt coverage for Anbio Biotechnology Class A Ordinary Shares. For the full company profile including market capitalisation, see NNNN company net worth.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2024 1.20x $2.08 Million $2.08 Million $1.73 Million ▲ +32.9%
2023 0.90x $898.37K $898.37K $993.06K ▼ -71.3%
2022 3.15x $4.45 Million $4.45 Million $1.41 Million ▲ +79.4%
2021 1.76x $4.18 Million $4.18 Million $2.38 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities